Invivyd, INC. 8-K Filing
Ticker: IVVD · Form: 8-K · Filed: Nov 24, 2025 · CIK: 1832038
| Field | Detail |
|---|---|
| Company | Invivyd, INC. (IVVD) |
| Form Type | 8-K |
| Filed Date | Nov 24, 2025 |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Invivyd, INC. (ticker: IVVD) to the SEC on Nov 24, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.0001 (ch registered Common stock, par value $0.0001 per share IVVD The Nasdaq Stock Mar).
How long is this filing?
Invivyd, INC.'s 8-K filing is 1 pages with approximately 432 words. Estimated reading time is 2 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 432 words · 2 min read · ~1 pages · Grade level 11.1 · Accepted 2025-11-24 07:06:00
Key Financial Figures
- $0.0001 — ch registered Common stock, par value $0.0001 per share IVVD The Nasdaq Stock Mar
Filing Documents
- ivvd-20251124.htm (8-K) — 56KB
- ivvd-ex99_1.htm (EX-99.1) — 25KB
- img59752938_0.jpg (GRAPHIC) — 84KB
- 0001193125-25-291992.txt ( ) — 316KB
- ivvd-20251124.xsd (EX-101.SCH) — 31KB
- ivvd-20251124_htm.xml (XML) — 5KB
01 Other Events
Item 8.01 Other Events. On November 24, 2025, Invivyd, Inc. issued a press release entitled "Invivyd Announces Selection of Potential Best-In-Class RSV Antibody Candidate VBY329; Targeting 2H 2026 IND Readiness." A copy of the press release is filed herewith as Exhibit 99.1 and is incorporated by reference in this Item 8.01.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release, dated November 24, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INVIVYD, INC. Date: November 24, 2025 By: /s/ Jill Andersen Jill Andersen Chief Legal Officer and Corporate Secretary